Pharmaceutical Patent Law 2009 Cumulative Supplement Author:John R. Thomas The 2009 Cumulative Supplement to Pharmaceutical Patent Law includes the following new information: Legislative developments in the 111th Congress concerning patents, follow-on biologics, and Hatch- Waxman reform The continuing impact of Supreme Court precedent upon pharmaceutical patent law, including the law of obviousness and declaratory judg... more »ment jurisdiction The new rules concerning the extension of the Hatch-Waxman Act's 30-month stay of marketing approval Coverage of judicial reaction to concerns over baseless paragraph IV ANDA filings Updated information on the construction of pharmaceutical patent claims« less